Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation

Biochimica et Biophysica Acta - General Subjects

Volumn 1860, Issue 8, 2016, Pages 1615-1622

  Prenc, Ema ^a   Pulanic, Drazen ^b,c,d   Pucic Bakovic, Maja ^e   Pezer, Marija ^e   Desnica, Lana ^b   Vrhovac, Radovan ^b,c   Nemet, Damir ^b,c,d   Pavletic, Steven Z ^f  

^a Croatian Cooperative Group for Hematologic Diseases   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^e GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Glycan; Glycosylation; Graft versus host disease; Hematopoietic stem cell transplantation

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; B CELL ACTIVATING FACTOR; FC RECEPTOR; GLYCAN; IMMUNOGLOBULIN G; PREDNISONE; RITUXIMAB; STEROID; T LYMPHOCYTE RECEPTOR; BIOLOGICAL MARKER;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; DRUG MEGADOSE; ENGRAFTMENT; FUCOSYLATION; GLYCOSYLATION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS TUMOR EFFECT; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; LYMPHOCYTE HOMING; NONHUMAN; PRIORITY JOURNAL; SIALYLATION; ACUTE DISEASE; ALLOGRAFT; ANIMAL; CHRONIC DISEASE; GENETICS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MEDICAL RESEARCH; METABOLISM; PROCEDURES;

ACUTE DISEASE; ALLOGRAFTS; ANIMALS; BIOMARKERS; BIOMEDICAL RESEARCH; CHRONIC DISEASE; GLYCOSYLATION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION;

EID: 84959860104     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2016.02.015     Document Type: Article

References (97)

1. G.W. Hart, and R.J. Copeland Glycomics hits the big time Cell 143 2010 672 676 10.1016/j.cell.2010.11.008
2. G.A. Rabinovich, Y. van Kooyk, and B.A. Cobb Glycobiology of immune responses Ann. N. Y. Acad. Sci. 1253 2012 10.1111/j.1749-6632.2012.06492.x
3. O. Gornik, and G. Lauc Glycosylation of serum proteins in Inflammatory diseases Dis. Markers 25 2008 267 278 10.1155/2008/493289
4. G. Lauc, J.E. Huffman, M. Pucic, L. Zgaga, B. Adamczyk, A. Muzinic, M. Novokmet, O. Polasek, O. Gornik, J. Kristic, T. Keser, V. Vitart, B. Scheijen, H.-W. Uh, M. Molokhia, A.L. Patrick, P. McKeigue, I. Kolcic, I.K. Lukic, O. Swann, F.N. van Leeuwen, L.R. Ruhaak, J.J. Houwing-Duistermaat, P.E. Slagboom, M. Beekman, A.J.M. de Craen, A.M. Deelder, Q. Zeng, W. Wang, N.D. Hastie, U. Gyllensten, J.F. Wilson, M. Wuhrer, A.F. Wright, P.M. Rudd, C. Hayward, Y. Aulchenko, H. Campbell, and I. Rudan Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers PLoS Genet. 9 2013 e1003225 10.1371/journal.pgen.1003225
5. I. Aurer, G. Lauc, J. Dumic, D. Rendic, D. Matisic, M. Milos, M. Heffer-Lauc, M. Flogel, and B. Labar Aberrant glycosylation of Igg heavy chain in multiple myeloma Coll. Antropol. 31 2007 247 251
6. G. Lauc, M. Pezer, I. Rudan, and H. Campbell Mechanisms of disease: the human N-glycome Biochim. Biophys. Acta 2015 10.1016/j.bbagen.2015.10.016
7. E. Maverakis, K. Kim, M. Shimoda, M.E. Gershwin, F. Patel, R. Wilken, S. Raychaudhuri, L.R. Ruhaak, and C.B. Lebrilla Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review J. Autoimmun. 57 2015 1 13 10.1016/j.jaut.2014.12.002
8. G. Lauc, I. Rudan, H. Campbell, and P.M. Rudd Complex genetic regulation of protein glycosylation Mol. BioSyst. 6 2010 329 335 10.1039/B910377E
9. K.W. Moremen, M. Tiemeyer, and A.V. Nairn Vertebrate protein glycosylation: diversity, synthesis and function Nat. Rev. Mol. Cell Biol. 13 2012 448 462 10.1038/nrm3383
10. O. Gornik, T. Pavic, and G. Lauc Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease Biochim. Biophys. Acta 1820 2012 1318 1326 10.1016/j.bbagen.2011.12.004
11. A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, and M.E. Etzler Essentials of Glycobiology second ed. 2009 Cold Spring Harbor Laboratory Press Cold Spring Harbor (NY) Available at http://www.ncbi.nlm.nih.gov/books/NBK1908/ (Accessed October 21, 2015)
12. S. Aschermann, A. Lux, A. Baerenwaldt, M. Biburger, and F. Nimmerjahn The other side of immunoglobulin G: suppressor of inflammation Clin. Exp. Immunol. 160 2010 161 167 10.1111/j.1365-2249.2009.04081.x
13. S. Böhm, I. Schwab, A. Lux, and F. Nimmerjahn The role of sialic acid as a modulator of the anti-inflammatory activity of IgG Semin. Immunopathol. 34 2012 443 453 10.1007/s00281-012-0308-x
14. M. Pucic, A. Knezevic, J. Vidic, B. Adamczyk, M. Novokmet, O. Polasek, O. Gornik, S. Supraha-Goreta, M.R. Wormald, I. Redzic, H. Campbell, A. Wright, N.D. Hastie, J.F. Wilson, I. Rudan, M. Wuhrer, P.M. Rudd, D. Josic, and G. Lauc High throughput isolation and glycosylation analysis of IgG - variability and heritability of the IgG glycome in three isolated human populations Mol. Cell. Proteomics 10 2011 M111.010090. doi: 10.1074/mcp.M111.010090
15. J. Kristic, F. Vuckovic, C. Menni, L. Klaric, T. Keser, I. Beceheli, M. Pucic-Bakovic, M. Novokmet, M. Mangino, K. Thaqi, P. Rudan, N. Novokmet, J. Sarac, S. Missoni, I. Kolcic, O. Polasek, I. Rudan, H. Campbell, C. Hayward, Y. Aulchenko, A. Valdes, J.F. Wilson, O. Gornik, D. Primorac, V. Zoldos, T. Spector, and G. Lauc Glycans are a novel biomarker of chronological and biological ages J. Gerontol. A Biol. Sci. Med. Sci. 69 2014 779 789 10.1093/gerona/glt190
16. C. Menni, T. Keser, M. Mangino, J.T. Bell, I. Erte, I. Akmacic, F. Vuckovic, M. Pucic Bakovic, O. Gornik, M.I. McCarthy, V. Zoldos, T.D. Spector, G. Lauc, and A.M. Valdes Glycosylation of immunoglobulin G: role of genetic and epigenetic influences PLoS One 8 2013 10.1371/journal.pone.0082558
17. O. Gornik, J. Wagner, M. Pucic, A. Knezevic, I. Redzic, and G. Lauc Stability of N-glycan profiles in human plasma Glycobiology 19 2009 1547 1553 10.1093/glycob/cwp134
18. Q.M. Hanson, and A.W. Barb A perspective on the structure and receptor binding properties of immunoglobulin G Fc Biochemistry 54 2015 2931 2942 10.1021/acs.biochem.5b00299
19. G.P. Subedi, and A.W. Barb The structural role of antibody N-glycosylation in receptor interactions Structure 23 2015 1573 1583 10.1016/j.str.2015.06.015
20. I. Quast, C.W. Keller, M.A. Maurer, J.P. Giddens, B. Tackenberg, L.-X. Wang, C. Münz, F. Nimmerjahn, M.C. Dalakas, and J.D. Lünemann Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity J. Clin. Invest. 125 2015 4160 4170 10.1172/JCI82695
21. C. Ferrara, S. Grau, C. Jäger, P. Sondermann, P. Brünker, I. Waldhauer, M. Hennig, A. Ruf, A.C. Rufer, M. Stihle, P. Umaña, and J. Benz Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose Proc. Natl. Acad. Sci. U. S. A. 108 2011 12669 12674 10.1073/pnas.1108455108
22. P. Sondermann, A. Pincetic, J. Maamary, K. Lammens, and J.V. Ravetch General mechanism for modulating immunoglobulin effector function Proc. Natl. Acad. Sci. U. S. A. 110 2013 9868 9872 10.1073/pnas.1307864110
23. I. Trbojevic Akmacic, N.T. Ventham, E. Theodoratou, F. Vuckovic, N.A. Kennedy, J. Kristic, E.R. Nimmo, R. Kalla, H. Drummond, J. Stambuk, M.G. Dunlop, M. Novokmet, Y. Aulchenko, O. Gornik, H. Campbell, M. Pucic Bakovic, J. Satsangi, and G. Lauc Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome Inflamm. Bowel Dis. 21 2015 1237 1247 10.1097/MIB.0000000000000372
24. F. Vuckovic, J. Kristic, I. Gudelj, M. Teruel, T. Keser, M. Pezer, M. Pucic-Bakovic, J. Stambuk, I. Trbojevic-Akmacic, C. Barrios, T. Pavic, C. Menni, Y. Wang, Y. Zhou, L. Cui, H. Song, Q. Zeng, X. Guo, B.A. Pons-Estel, P. McKeigue, A. Leslie Patrick, O. Gornik, T.D. Spector, M. Harjacek, M. Alarcon-Riquelme, M. Molokhia, W. Wang, and G. Lauc Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome Arthritis Rheumatol. 67 2015 2978 2989 10.1002/art.39273
25. K.M. Schweitzer, A.M. Dräger, P. van der Valk, S.F. Thijsen, A. Zevenbergen, A.P. Theijsmeijer, C.E. van der Schoot, and M.M. Langenhuijsen Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues Am. J. Pathol. 148 1996 165 175
26. L.K. Nabors, L.D. Wang, A.J. Wagers, and G.S. Kansas Overlapping roles for endothelial selectins in murine hematopoietic stem/progenitor cell homing to bone marrow Exp. Hematol. 41 2013 588 596 10.1016/j.exphem.2013.02.014
27. I.G. Winkler, V. Barbier, B. Nowlan, R.N. Jacobsen, C.E. Forristal, J.T. Patton, J.L. Magnani, and J.-P. Lévesque Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance Nat. Med. 18 2012 1651 1657 10.1038/nm.2969
28. R. Sackstein The bone marrow Is akin to skin: HCELL and the biology of hematopoietic stem cell homing J. Investig. Dermatol. 122 2004 1061 1069 10.1111/j.0022-202X.2004.09301.x
29. M. Nasirikenari, L. Veillon, C.C. Collins, P. Azadi, and J.T.Y. Lau Remodeling of marrow hematopoietic stem and progenitor cells by non-self ST6Gal-1 sialyltransferase J. Biol. Chem. 289 2014 7178 7189 10.1074/jbc.M113.508457
30. R. Sackstein Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration Ann. Biomed. Eng. 40 2011 766 776 10.1007/s10439-011-0461-8
31. S.N. Robinson, M.W. Thomas, P.J. Simmons, J. Lu, H. Yang, S. Parmar, X. Liu, N. Shah, B. Martín-Antonio, C. Bollard, G. Dotti, B. Savoldo, L.J. Cooper, A. Najjar, K. Rezvani, I. Kaur, I.K. McNiece, R.E. Champlin, L.P. Miller, P.A. Zweidler-McKay, and E.J. Shpall Fucosylation with fucosyltransferase (FT)-VI or FT-VII improves cord blood engraftment Cytotherapy 16 2014 84 89 10.1016/j.jcyt.2013.07.003
32. A.H. Filipovich, D. Weisdorf, S. Pavletic, G. Socie, J.R. Wingard, S.J. Lee, P. Martin, J. Chien, D. Przepiorka, D. Couriel, E.W. Cowen, P. Dinndorf, A. Farrell, R. Hartzman, J. Henslee-Downey, D. Jacobsohn, G. McDonald, B. Mittleman, J.D. Rizzo, M. Robinson, M. Schubert, K. Schultz, H. Shulman, M. Turner, G. Vogelsang, and M.E.D. Flowers National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I Diagnosis and Staging Working Group Report Biol. Blood Marrow Transplant 11 2005 945 956 10.1016/j.bbmt.2005.09.004
33. M.H. Jagasia, H.T. Greinix, M. Arora, K.M. Williams, D. Wolff, E.W. Cowen, J. Palmer, D. Weisdorf, N.S. Treister, G.-S. Cheng, H. Kerr, P. Stratton, R.F. Duarte, G.B. McDonald, Y. Inamoto, A. Vigorito, S. Arai, M.B. Datiles, D. Jacobsohn, T. Heller, C.L. Kitko, S.A. Mitchell, P.J. Martin, H. Shulman, R.S. Wu, C.S. Cutler, G.B. Vogelsang, S.J. Lee, S.Z. Pavletic, and M.E.D. Flowers National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I The 2014 Diagnosis and Staging Working Group Report Biol. Blood Marrow Transplant. 21 2015 389-401.e1 10.1016/j.bbmt.2014.12.001
34. F.L. Dignan, A. Clark, P. Amrolia, J. Cornish, G. Jackson, P. Mahendra, J.J. Scarisbrick, P.C. Taylor, N. Hadzic, B.E. Shaw, M.N. Potter, and on behalf of the Haemato-oncology Task Force of the British Committee for Standards in Haematology and the British Society for Blood and Marrow Transplantation Diagnosis and management of acute graft-versus-host disease Br. J. Haematol. 158 2012 30 45 10.1111/j.1365-2141.2012.09129.x
35. L. Johnston Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity Best Pract. Res. Clin. Haematol. 21 2008 177 192 10.1016/j.beha.2008.02.006
36. Y. Maeda Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses Int. J. Hematol. 98 2013 293 299 10.1007/s12185-013-1421-x
37. A. Ramadan, and S. Paczesny Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation Front. Immunol. 6 2015 10.3389/fimmu.2015.00014
38. M. Novokmet, E. Lukic, F. Vuckovic, Z. Duric, T. Keser, K. Rajsl, D. Remondini, G. Castellani, H. Gasparovic, O. Gornik, and G. Lauc Changes in IgG and total plasma protein glycomes in acute systemic inflammation Sci. Rep. 4 2014 10.1038/srep04347
39. O. Gornik, L. Royle, D.J. Harvey, C.M. Radcliffe, R. Saldova, R.A. Dwek, P. Rudd, and G. Lauc Changes of serum glycans during sepsis and acute pancreatitis Glycobiology 17 2007 1321 1332 10.1093/glycob/cwm106
40. E.L. Naka, V.C. Ponciano, M.A. Cenedeze, A. Pacheco-Silva, and N.O. Saraiva Câmara Detection of the Tim-3 ligand, galectin-9, inside the allograft during a rejection episode Int. Immunopharmacol. 9 2009 658 662 10.1016/j.intimp.2008.11.013
41. C. Wu, T. Thalhamer, R.F. Franca, S. Xiao, C. Wang, C. Hotta, C. Zhu, M. Hirashima, A.C. Anderson, and V.K. Kuchroo Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T Cells Immunity 41 2014 270 282 10.1016/j.immuni.2014.06.011
42. V.R. Wiersma, M. de Bruyn, W. Helfrich, and E. Bremer Therapeutic potential of galectin-9 in human disease Med. Res. Rev. 33 2013 E102 E126 10.1002/med.20249
43. K. Sakai, E. Kawata, E. Ashihara, Y. Nakagawa, A. Yamauchi, H. Yao, R. Nagao, R. Tanaka, A. Yokota, M. Takeuchi, H. Hirai, S. Kimura, M. Hirashima, N. Yoshimura, and T. Maekawa Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis Eur. J. Immunol. 41 2011 67 75 10.1002/eji.200939931
44. S.W. Choi, J.E. Levine, and J.L.M. Ferrara Pathogenesis and management of graft versus host disease Immunol. Allergy Clin. N. Am. 30 2010 75 101 10.1016/j.iac.2009.10.001
45. S.J. Lee, and M.E.D. Flowers Recognizing and managing chronic graft-versus-host disease Hematology 2008 2008 134 141 10.1182/asheducation-2008.1.134
46. S. Arai, M. Arora, T. Wang, S.R. Spellman, W. He, D.R. Couriel, A. Urbano-Ispizua, C.S. Cutler, A.A. Bacigalupo, M. Battiwalla, M.E. Flowers, M.B. Juckett, S.J. Lee, A.W. Loren, T.R. Klumpp, S.E. Prockup, O.T.H. Ringdén, B.N. Savani, G. Socié, K.R. Schultz, T. Spitzer, T. Teshima, C.N. Bredeson, D.A. Jacobsohn, R.J. Hayashi, W.R. Drobyski, H.A. Frangoul, G. Akpek, V.T. Ho, V.A. Lewis, R.P. Gale, J. Koreth, N.J. Chao, M.D. Aljurf, B.W. Cooper, M.J. Laughlin, J.W. Hsu, P. Hematti, L.F. Verdonck, M.M. Solh, M. Norkin, V. Reddy, R. Martino, S. Gadalla, J.D. Goldberg, P.L. McCarthy, J.A. Pérez-Simón, N. Khera, I.D. Lewis, Y. Atsuta, R.F. Olsson, W. Saber, E.K. Waller, D. Blaise, J.A. Pidala, P.J. Martin, P. Satwani, M. Bornhäuser, Y. Inamoto, D.J. Weisdorf, M.M. Horowitz, and S.Z. Pavletic Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the center for international blood and marrow transplant research Biol. Blood Marrow Transplant. 21 2015 266 274 10.1016/j.bbmt.2014.10.021
47. P.J. Martin, D. Weisdorf, D. Przepiorka, S. Hirschfeld, A. Farrell, J.D. Rizzo, R. Foley, G. Socie, S. Carter, D. Couriel, K.R. Schultz, M.E.D. Flowers, A.H. Filipovich, R. Saliba, G.B. Vogelsang, S.Z. Pavletic, and S.J. Lee National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI Design of Clinical Trials Working Group Report Biol. Blood Marrow Transplant. 12 2006 491 505 10.1016/j.bbmt.2006.03.004
48. H.M. Shulman, D. Kleiner, S.J. Lee, T. Morton, S.Z. Pavletic, E. Farmer, J.M. Moresi, J. Greenson, A. Janin, P.J. Martin, G. McDonald, M.E.D. Flowers, M. Turner, J. Atkinson, J. Lefkowitch, M.K. Washington, V.G. Prieto, S.K. Kim, Z. Argenyi, A.H. Diwan, A. Rashid, K. Hiatt, D. Couriel, K. Schultz, S. Hymes, and G.B. Vogelsang Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II Pathology Working Group Report Biol. Blood Marrow Transplant. 12 2006 31 47 10.1016/j.bbmt.2005.10.023
49. K.R. Schultz, D.B. Miklos, D. Fowler, K. Cooke, J. Shizuru, E. Zorn, E. Holler, J. Ferrara, H. Shulman, S.J. Lee, P. Martin, A.H. Filipovich, M.E.D. Flowers, D. Weisdorf, D. Couriel, P.A. Lachenbruch, B. Mittleman, G.B. Vogelsang, and S.Z. Pavletic Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III Biomarker Working Group Report Biol. Blood Marrow Transplant. 12 2006 126 137 10.1016/j.bbmt.2005.11.010
50. S.Z. Pavletic, P. Martin, S.J. Lee, S. Mitchell, D. Jacobsohn, E.W. Cowen, M.L. Turner, G. Akpek, A. Gilman, G. McDonald, M. Schubert, A. Berger, P. Bross, J.W. Chien, D. Couriel, J.P. Dunn, J. Fall-Dickson, A. Farrell, M.E.D. Flowers, H. Greinix, S. Hirschfeld, L. Gerber, S. Kim, R. Knobler, P.A. Lachenbruch, F.W. Miller, B. Mittleman, E. Papadopoulos, S.K. Parsons, D. Przepiorka, M. Robinson, M. Ward, B. Reeve, L.G. Rider, H. Shulman, K.R. Schultz, D. Weisdorf, and G.B. Vogelsang Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV Response Criteria Working Group Report Biol. Blood Marrow Transplant. 12 2006 252 266 10.1016/j.bbmt.2006.01.008
51. D. Couriel, P.A. Carpenter, C. Cutler, J. Bolaños-Meade, N.S. Treister, J. Gea-Banacloche, P. Shaughnessy, S. Hymes, S. Kim, A.S. Wayne, J.W. Chien, J. Neumann, S. Mitchell, K. Syrjala, C.K. Moravec, L. Abramovitz, J. Liebermann, A. Berger, L. Gerber, M. Schubert, A.H. Filipovich, D. Weisdorf, M.M. Schubert, H. Shulman, K. Schultz, B. Mittelman, S. Pavletic, G.B. Vogelsang, P.J. Martin, S.J. Lee, and M.E.D. Flowers Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V Ancillary Therapy and Supportive Care Working Group Report Biol. Blood Marrow Transplant. 12 2006 375 396 10.1016/j.bbmt.2006.02.003
52. H.M. Shulman, D.M. Cardona, J.K. Greenson, S. Hingorani, T. Horn, E. Huber, A. Kreft, T. Longerich, T. Morton, D. Myerson, V.G. Prieto, A. Rosenberg, N. Treister, K. Washington, M. Ziemer, S.Z. Pavletic, S.J. Lee, M.E.D. Flowers, K.R. Schultz, M. Jagasia, P.J. Martin, G.B. Vogelsang, and D.E. Kleiner NIH Consensus Development project on criteria for clinical trials in chronic graft-versus-host disease: II The 2014 Pathology Working Group report Biol. Blood Marrow Transplant 21 2015 589 603 10.1016/j.bbmt.2014.12.031
53. S. Paczesny, F.T. Hakim, J. Pidala, K. Cooke, J. Lathrop, L.M. Griffith, J. Hansen, M. Jagasia, D. Miklos, S. Pavletic, R. Parkman, E. Russek-Cohen, M.E.D. Flowers, S. Lee, P. Martin, G. Vogelsang, M. Walton, K.R. Schultz, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. The 2014 Biomarker Working Group Report, Biol. Blood Marrow Transplant. 21 (2015) 780-92. doi: http://dx.doi.org/10.1016/j.bbmt.2015.01.003
54. S.J. Lee, D. Wolff, C. Kitko, J. Koreth, Y. Inamoto, M. Jagasia, J. Pidala, A. Olivieri, P.J. Martin, D. Przepiorka, I. Pusic, F. Dignan, S.A. Mitchell, A. Lawitschka, D. Jacobsohn, A.M. Hall, M.E.D. Flowers, K.R. Schultz, G. Vogelsang, and S. Pavletic Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV The 2014 Response Criteria Working Group report Biol. Blood Marrow Transplant. 21 2015 984 999 10.1016/j.bbmt.2015.02.025
55. P.A. Carpenter, C.L. Kitko, S. Elad, M.E.D. Flowers, J.C. Gea-Banacloche, J.P. Halter, F. Hoodin, L. Johnston, A. Lawitschka, G.B. McDonald, A.W. Opipari, B.N. Savani, K.R. Schultz, S.R. Smith, K.L. Syrjala, N. Treister, G.B. Vogelsang, K.M. Williams, S.Z. Pavletic, P.J. Martin, S.J. Lee, and D.R. Couriel National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V The 2014 Ancillary Therapy and Supportive Care Working Group Report Biol. Blood Marrow Transplant 21 2015 1167 1187 10.1016/j.bbmt.2015.03.024
56. P.J. Martin, S.J. Lee, D. Przepiorka, M.M. Horowitz, J. Koreth, G.B. Vogelsang, I. Walker, P.A. Carpenter, L.M. Griffith, G. Akpek, M. Mohty, D. Wolff, S.Z. Pavletic, C.S. Cutler, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. The 2014 Clinical Trial Design Working Group Report, Biol. Blood Marrow Transplant. 21 (2015) 1343-1359. doi: http://dx.doi.org/10.1016/j.bbmt.2015.05.004
57. J.M. Coghill, S. Sarantopoulos, T.P. Moran, W.J. Murphy, B.R. Blazar, and J.S. Serody Effector CD4 + T cells, the cytokines they generate, and GVHD: something old and something new Blood 117 2011 3268 3276 10.1182/blood-2010-12-290403
58. B.R. Blazar, W.J. Murphy, and M. Abedi Advances in graft-versus-host disease biology and therapy Nat. Rev. Immunol. 12 2012 443 458 10.1038/nri3212
59. A. Shimabukuro-Vornhagen, M.J. Hallek, R.F. Storb, and M.S. von Bergwelt-Baildon The role of B cells in the pathogenesis of graft-versus-host disease Blood 114 2009 4919 4927 10.1182/blood-2008-10-161638
60. J.S. Young, T. Wu, Y. Chen, D. Zhao, H. Liu, T. Yi, H. Johnston, J. Racine, X. Li, A. Wang, I. Todorov, and D. Zeng Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4 + T cells that mediate autoimmune-like chronic GVHD J. Immunol. 189 2012 222 233 10.4049/jimmunol.1200677
61. S. Sarantopoulos, and J. Ritz Aberrant B cell homeostasis in chronic GVHD Blood 125 2015 1703 1707 10.1182/blood-2014-12-567834
62. J.L. Allen, M.S. Fore, J. Wooten, P.A. Roehrs, N.S. Bhuiya, T. Hoffert, A. Sharf, A.M. Deal, P. Armistead, J. Coghill, D.A. Gabriel, R. Irons, A. Essenmacher, T.C. Shea, K. Richards, C. Cutler, J. Ritz, J. Serody, A.S. Baldwin, and S. Sarantopoulos B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways Blood 120 2012 2529 2536 10.1182/blood-2012-06-438911
63. S. Sarantopoulos, K.E. Stevenson, H.T. Kim, C.S. Cutler, N.S. Bhuiya, M. Schowalter, V.T. Ho, E.P. Alyea, J. Koreth, B.R. Blazar, R.J. Soiffer, J.H. Antin, and J. Ritz Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease Blood 113 2009 3865 3874 10.1182/blood-2008-09-177840
64. C.A. Jacobson, L. Sun, H.T. Kim, S.M. McDonough, C.G. Reynolds, M. Schowalter, J. Koreth, C.S. Cutler, V.T. Ho, E.P. Alyea, P. Armand, B.R. Blazar, R.J. Soiffer, J.H. Antin, J. Ritz, and S. Sarantopoulos Post-transplantation B Cell activating factor and B Cell recovery before onset of chronic graft-versus-host disease Biol. Blood Marrow Transplant. 20 2014 668 675 10.1016/j.bbmt.2014.01.021
65. R. Brink Regulation of B cell self-tolerance by BAFF Semin. Immunol. 18 2006 276 283 10.1016/j.smim.2006.04.003
66. S. Sarantopoulos, K.E. Stevenson, H.T. Kim, N.S. Bhuiya, C.S. Cutler, R.J. Soiffer, J.H. Antin, and J. Ritz High levels of B-cell activating factor in patients with active chronic graft-versus-host disease Clin. Cancer Res. 13 2007 6107 6114 10.1158/1078-0432.CCR-07-1290
67. C. Cutler, H.T. Kim, B. Bindra, S. Sarantopoulos, V.T. Ho, Y.-B. Chen, J. Rosenblatt, S. McDonough, P. Watanaboonyongcharoen, P. Armand, J. Koreth, B. Glotzbecker, E. Alyea, B.R. Blazar, R.J. Soiffer, J. Ritz, and J.H. Antin Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial Blood 122 2013 1510 1517 10.1182/blood-2013-04-495895
68. S. Arai, B. Sahaf, B. Narasimhan, G.L. Chen, C.D. Jones, R. Lowsky, J.A. Shizuru, L.J. Johnston, G.G. Laport, W.-K. Weng, J.E. Benjamin, J. Schaenman, J. Brown, J. Ramirez, J.L. Zehnder, R.S. Negrin, and D.B. Miklos Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence Blood 119 2012 6145 6154 10.1182/blood-2011-12-395970
69. S. Sarantopoulos, K.E. Stevenson, H.T. Kim, W.S. Washel, N.S. Bhuiya, C.S. Cutler, E.P. Alyea, V.T. Ho, R.J. Soiffer, J.H. Antin, and J. Ritz Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease Blood 117 2011 2275 2283 10.1182/blood-2010-10-307819
70. W. Alduaij, and T.M. Illidge The future of anti-CD20 monoclonal antibodies: are we making progress? Blood 117 2011 2993 3001 10.1182/blood-2010-07-298356
71. C. Kellner, S. Derer, T. Valerius, and M. Peipp Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions Methods 65 2014 105 113 10.1016/j.ymeth.2013.06.036
72. Z. Kuzmina, V. Gounden, L. Curtis, D. Avila, T.T. Rnp, J. Baruffaldi, E.W. Cowen, H.B. Naik, S.A. Hasni, J.W. Mays, S. Mitchell, K. Baird, S.M. Steinberg, and S.Z. Pavletic Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria Am. J. Hematol. 90 2015 114 119 10.1002/ajh.23885
73. T. Dörner, C. Giesecke, and P.E. Lipsky Mechanisms of B cell autoimmunity in SLE Arthritis Res. Ther. 13 2011 243 10.1186/ar3433
74. D. Cornec, V. Devauchelle-Pensec, G.J. Tobón, J.-O. Pers, S. Jousse-Joulin, and A. Saraux B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment J. Autoimmun. 39 2012 161 167 10.1016/j.jaut.2012.05.014
75. A. François, E. Chatelus, D. Wachsmann, J. Sibilia, S. Bahram, G. Alsaleh, and J.-E. Gottenberg B lymphocytes and B-cell activating factor promote Collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis Arthritis Res. Ther. 15 2013 R168 10.1186/ar4352
76. J.-O. Pers, C. Daridon, V. Devauchelle, S. Jousse, A. Saraux, C. Jamin, and P. Youinou BAFF overexpression Is associated with autoantibody production in autoimmune diseases Ann. N. Y. Acad. Sci. 1050 2005 34 39 10.1196/annals.1313.004
77. M. Eggert, U.K. Zettl, and G. Neeck Autoantibodies in autoimmune diseases Curr. Pharm. Des. 16 2010 1634 1643
78. A. Tyndall, and F. Dazzi Chronic GVHD as an autoimmune disease Best Pract. Res. Clin. Haematol. 21 2008 281 289 10.1016/j.beha.2008.03.003
79. T. Daikeler, and A. Tyndall Autoimmunity following haematopoietic stem-cell transplantation Best Pract. Res. Clin. Haematol. 20 2007 349 360 10.1016/j.beha.2006.09.008
80. P. Youinou, Y.-L. Pennec, R. Casburn-Budd, M. Dueymes, G. Letoux, and A. Lamour Galactose terminating oligosaccharides of IgG in patients with primary Sjögren's syndrome J. Autoimmun. 5 1992 393 400 10.1016/0896-8411(92)90151-F
81. I. Castro, D. Sepúlveda, J. Cortés, A.F.G. Quest, M.J. Barrera, V. Bahamondes, S. Aguilera, U. Urzúa, C. Alliende, C. Molina, S. González, M.A. Hermoso, C. Leyton, and M.J. González Oral dryness in Sjögren's syndrome patients. Not just a question of water Autoimmun. Rev. 12 2013 567 574 10.1016/j.autrev.2012.10.018
82. S. Yurasov, H. Wardemann, J. Hammersen, M. Tsuiji, E. Meffre, V. Pascual, and M.C. Nussenzweig Defective B cell tolerance checkpoints in systemic lupus erythematosus J. Exp. Med. 201 2005 703 711 10.1084/jem.20042251
83. C. Panzironi, M. Mo, D. Mruk, C.Y. Cheng, B. Silvestrini, and R. Lahita An increase in the carbohydrate moiety of α2-macroglobulin is associated with systemic lupus erythematosus (SLE) Biochem. Mol. Biol. Int. 43 1997 1305 1322 10.1080/15216549700205131
84. X.-X. Chen, Y.-Q. Chen, and S. Ye Measuring decreased serum IgG sialylation: a novel clinical biomarker of lupus Lupus 0961203315570686 2015 10.1177/0961203315570686
85. J.M.H. Larsson, H. Karlsson, J.G. Crespo, M.E.V. Johansson, L. Eklund, H. Sjövall, and G.C. Hansson Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation Inflamm. Bowel Dis. 17 2011 2299 2307 10.1002/ibd.21625
86. E. Theodoratou, H. Campbell, N.T. Ventham, D. Kolarich, M. Pucic-Bakovic, V. Zoldos, D. Fernandes, I.K. Pemberton, I. Rudan, N.A. Kennedy, M. Wuhrer, E. Nimmo, V. Annese, D.P.B. McGovern, J. Satsangi, and G. Lauc The role of glycosylation in IBD Nat. Rev. Gastroenterol. Hepatol. 11 2014 588 600 10.1038/nrgastro.2014.78
87. A.M. Dias, J. Dourado, P. Lago, J. Cabral, R. Marcos-Pinto, P. Salgueiro, C.R. Almeida, S. Carvalho, S. Fonseca, M. Lima, M. Vilanova, M. Dinis-Ribeiro, C.A. Reis, and S.S. Pinho Dysregulation of T cell receptor N-glycosylation: a molecular mechanism involved in ulcerative colitis Hum. Mol. Genet. 23 2013 2416 2427 10.1093/hmg/ddt632
88. M. Faraci, M. Zecca, M. Pillon, A. Rovelli, M.C. Menconi, M. Ripaldi, F. Fagioli, M. Rabusin, O. Ziino, E. Lanino, F. Locatelli, T. Daikeler, and A. Prete Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience Biol. Blood Marrow Transplant 20 2014 272 278 10.1016/j.bbmt.2013.11.014
89. D.A. Jacobsohn, M. Arora, J.P. Klein, A. Hassebroek, M.E. Flowers, C.S. Cutler, A. Urbano-Ispizua, B.J. Bolwell, J.H. Antin, M. Boyiadzis, J.-Y. Cahn, M.S. Cairo, R.H. Herzig, L.M. Isola, T.R. Klumpp, S.J. Lee, E.W. Petersdorf, S. Santarone, R.P. Gale, H.C. Schouten, S.R. Spellman, D.J. Weisdorf, J.R. Wingard, M.M. Horowitz, and S.Z. Pavletic Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease Blood 118 2011 4472 4479 10.1182/blood-2011-04-349068
90. S.Z. Pavletic, L.M. Smith, M.R. Bishop, J.C. Lynch, S.R. Tarantolo, J.M. Vose, P.J. Bierman, A. Hadi, J.O. Armitage, and A. Kessinger Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation Am. J. Hematol. 78 2005 265 274 10.1002/ajh.20275
91. D. Pulanic, J.N. Lozier, and S.Z. Pavletic Thrombocytopenia and hemostatic disorders in chronic graft versus host disease Bone Marrow Transplant. 44 2009 393 403 10.1038/bmt.2009.196
92. T. Bakchoul, K. Walek, A. Krautwurst, M. Rummel, G. Bein, S. Santoso, and U.J. Sachs Glycosylation of autoantibodies: insights into the mechanisms of immune thrombocytopenia Thromb. Haemost. 110 2013 1259 1266 10.1160/TH13-04-0294
93. O. Grauer, D. Wolff, H. Bertz, H. Greinix, J.-S. Kühl, A. Lawitschka, S.J. Lee, S.Z. Pavletic, E. Holler, and I. Kleiter Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the consensus conference on Clinical practice in chronic graft-versus-host disease Brain 133 2010 2852 2865 10.1093/brain/awq245
94. M.H.J. Selman, E.H. Niks, M.J. Titulaer, J.J.G.M. Verschuuren, M. Wuhrer, and A.M. Deelder IgG Fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis J. Proteome Res. 10 2011 143 152 10.1021/pr1004373
95. I. Perdivara, S.D. Peddada, F.W. Miller, K.B. Tomer, and L.J. Deterding Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes J. Proteome Res. 10 2011 2969 2978 10.1021/pr200397h
96. M. Dalziel, M. Crispin, C.N. Scanlan, N. Zitzmann, and R.A. Dwek Emerging principles for the therapeutic exploitation of glycosylation Science 343 2014 1235681 10.1126/science.1235681
97. C.H. Seow, J.M. Stempak, W. Xu, H. Lan, A.M. Griffiths, G.R. Greenberg, A.H. Steinhart, N. Dotan, and M.S. Silverberg Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype Am. J. Gastroenterol. 104 2009 1426 1434 10.1038/ajg.2009.79